Traws Pharma (TRAW)
NASDAQ:TRAW
Holding TRAW?
Track your performance easily

Traws Pharma (TRAW) Technical Analysis

1,795 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Traws Pharma’s (TRAW) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Traws Pharma is a Sell.
Traws Pharma’s (TRAW) 20-Day exponential moving average is 0.36, while Traws Pharma’s (TRAW) share price is $0.34, making it a Sell.
Traws Pharma’s (TRAW) 50-Day exponential moving average is 0.39, while Traws Pharma’s (TRAW) share price is $0.34, making it a Sell.

Traws Pharma (TRAW) Pivot Points

Sep 20, 2024, 02:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.33
0.34
0.34
0.35
0.35
0.36
0.36
Fibonacci
0.34
0.34
0.34
0.35
0.35
0.35
0.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Traws Pharma (TRAW) Moving Averages

Sep 20, 2024, 02:44 PM
Period
Simple
Exponential
MA5
0.34Buy
0.34Sell
MA10
0.35Sell
0.35Sell
MA20
0.36Sell
0.36Sell
MA50
0.38Sell
0.39Sell
MA100
0.48Sell
0.47Sell
MA200
0.62Sell
0.57Sell
Traws Pharma’s (TRAW) 10-Day exponential moving average is 0.35, while Traws Pharma’s (TRAW) share price is $0.34, making it a Sell.
Traws Pharma’s (TRAW) 100-Day exponential moving average is 0.47, while Traws Pharma’s (TRAW) share price is $0.34, making it a Sell.
Traws Pharma’s (TRAW) stock price is $0.34 and Traws Pharma’s (TRAW) 50-day simple moving average is 0.38, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $0.34 and Traws Pharma’s (TRAW) 100-day simple moving average is 0.48, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $0.34 and Traws Pharma’s (TRAW) 200-day simple moving average is 0.62, creating a Sell signal.

Traws Pharma (TRAW) Technical Indicators

Sep 20, 2024, 02:44 PM
Name
Value
Implied Action
RSI (14)
42.45
Neutral
STOCH (9,6)
30.05
Neutral
STOCHRSI (14)
27.25
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
29.16
Neutral
Williams %R
-73.33
Buy
CCI (14)
-121.57
Buy
ATR (14)
0.03
-
Ultimate Oscillator
36.42
Neutral
ROC
-8.11
Sell
Traws Pharma’s (TRAW) Relative Strength Index (RSI) is 42.45, creating a Neutral signal.
Traws Pharma’s (TRAW) Trend Strength Indicator (ADX) is 29.16, creating a Neutral signal.
Traws Pharma’s (TRAW) Commodity Channel Index (CCI) is -121.57, creating a Buy signal.
Traws Pharma’s (TRAW) Price Rate of Change (ROC) is -8.11, creating a Sell signal.

FAQ

Is TRAW a Buy, Hold, or Sell?
Based on TRAW’s technical indicators, TRAW is a Strong Sell.
    What is TRAW’s RSI (14)?
    TRAW’s RSI (14) is 42.45, which suggests TRAW is a Neutral.
      What is TRAW’s MACD?
      TRAW’s MACD is -0.01, which suggests TRAW is a Sell.
        What is TRAW’s 5-day moving average?
        TRAW’s 5-day moving average is 0.34, which suggests TRAW is a Buy.
          What is TRAW’s 20-day moving average?
          TRAW 20-day moving average is 0.36, which suggests TRAW is a Sell.
            What is TRAW’s 50-day moving average?
            TRAW’s 50-day moving average is 0.38, which suggests TRAW is a Sell.
              What is TRAW’s 200-day moving average?
              TRAW’s 200-day moving average is 0.62, which suggests TRAW is a Sell.
                What is TRAW’s Williams % R (14)?
                TRAW’s Williams % R (14) is -73.33, which suggests TRAW is a Buy.
                  What is TRAW’s CCI (14)?
                  TRAW’s CCI (14) is -121.57, which suggests TRAW is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis